Skip to content
In Stock Amantadine
Neurology

Amantadine

Amantadine helps alter dopamine signalling in the brain and is used in Parkinson’s disease and medication-related movement disorders. It may support motor control and reduce dyskinesia in selected…

Guaranteed quality Original product
Delivery: from 4 days Discreet shipping
24/7 Support Always available
Active ingredient: Amantadine
Select dosage:
Select pack Package Per unit Price
$ 4.01 $ 240.30
$ 3.66 $ 360.45 $ 329.30 Save 9%
Free Regular Delivery $ 3.49 $ 480.60 $ 418.30 Save 13%
Free Express Delivery $ 3.26 $ 720.90 $ 587.40 Save 19%
Free Express Delivery $ 3.18 $ 1,081.35 $ 859.74 Save 20%
Best value Free Express Delivery $ 3.08 $ 1,441.80 $ 1,108.94 Save 23%
$ 1.13 $ 33.82
$ 1.01 $ 67.64 $ 60.52 Save 11%
$ 0.93 $ 101.46 $ 83.66 Save 18%
$ 0.88 $ 135.28 $ 105.02 Save 22%
$ 0.79 $ 202.92 $ 142.40 Save 30%
Best value $ 0.67 $ 304.38 $ 181.56 Save 40%

Free delivery on orders from $ 356.00, free express delivery from $ 534.00

Secure payment methods:
VISA AMEX JCB DISCOVER

Amantadine helps alter dopamine signalling in the brain and is used in Parkinson’s disease and medication-related movement disorders. It may support motor control and reduce dyskinesia in selected adults.

Product information

Amantadine is an oral antiparkinsonian medicine supplied as pills containing amantadine hydrochloride. The amount taken at each intake is set individually for each person rather than being one fixed number. Neurologists may use it for Parkinson’s disease symptoms, secondary parkinsonism, or involuntary movements associated with dopaminergic treatment.

Ingredients

Amantadine pills contain amantadine hydrochloride. The marking on the pack identifies the product as Amantadine HCl 100 mg.

Therapeutic indications

Amantadine is an oral antiparkinsonian medicine supplied as pills containing amantadine hydrochloride 100 mg. Neurologists may use it for Parkinson’s disease symptoms, secondary parkinsonism, or involuntary movements associated with dopaminergic treatment. Its role depends on the person’s symptoms, kidney function, other medicines, and response over time.

The medicine is not a universal replacement for levodopa. It is usually considered as one part of a broader neurological treatment plan, especially when tremor, slowness, rigidity, motor fluctuations, or dyskinesia interfere with daily activities. The Australian Therapeutic Goods Administration (TGA), the European Medicines Agency (EMA), and United States prescribing information describe amantadine as a centrally acting medicine requiring attention to renal clearance and neurological adverse effects [1].

Management of Parkinson’s Disease Symptoms

Parkinson’s disease involves the progressive loss of dopamine-producing nerve cells in the substantia nigra. Reduced dopamine affects movement initiation, muscle tone, balance, and coordination. Amantadine may provide symptomatic support by influencing dopamine transmission and glutamate activity within the central nervous system.

Clinical use is individualised. Some people notice better mobility or less medication-related dyskinesia, while others experience limited benefit or troublesome effects such as insomnia, dizziness, ankle swelling, hallucinations, or confusion. Older adults and people with reduced kidney function need closer dose selection because amantadine leaves the body mainly through the kidneys.

The medicine may also be used for secondary parkinsonism, depending on its cause. A neurologist may review gait, rigidity, tremor, involuntary movements, alertness, kidney function, and the timing of other Parkinson’s medicines before adjusting treatment.

Keep a simple record of the time each dose is taken, the timing of involuntary movements, and any sleep or confusion changes. This gives the prescriber more useful information than a general statement that the medicine is or is not working.

Directions for use

Amantadine pills are taken by mouth, with the amount per intake set individually for each person rather than being one fixed number. The total daily schedule depends on the indication, age, kidney function, response, and other neurological medicines.

Typical administration principles include:

  • Take the pills by mouth at the prescribed times.
  • Swallow each pill with water.
  • Avoid changing the number of pills or dosing frequency without a prescriber’s instruction.
  • If a dose is missed, take it when remembered unless the next scheduled dose is near.
  • Do not double the next intake to compensate for a missed dose.
  • Avoid taking a late dose if it predictably causes insomnia, unless the prescriber has specifically instructed otherwise.
  • Do not stop treatment suddenly after regular use.

A late-day dose can disturb sleep because Amantadine may cause alertness or insomnia. Some patients also mistake worsening dyskinesia for a need to take an extra pill. That can increase dizziness, confusion, or hallucinations without correcting the underlying motor fluctuation.

If a missed dose is close to the next scheduled dose, skip the missed intake rather than taking two together. Record the missed time and return to the prescribed schedule.

When not to use it

  • You have had a serious allergic reaction to amantadine or an ingredient in the formulation.
  • You have severe kidney impairment unless a specialist has selected and monitored an adjusted regimen.
  • You have uncontrolled psychosis or severe confusion that could worsen with dopaminergic or central nervous system effects.
  • You have a history of seizures requiring careful neurological management, unless the prescriber has judged the treatment appropriate.
  • You are taking another medicine that may significantly prolong the QT interval or increase arrhythmia risk without a reviewed treatment plan.
  • You have untreated narrow-angle glaucoma or another eye condition for which anticholinergic-type effects could be hazardous.
  • You are pregnant or breastfeeding and the potential benefit has not been assessed for your circumstances.

When this is not for you

Amantadine is not suitable for everyone. Talk to a prescriber before using it if you have kidney problems, confusion, hallucinations, seizures, fainting, heart rhythm disease, swelling, recurrent falls, glaucoma, or an allergy to amantadine. You should also seek medical advice if you are pregnant or breastfeeding, or if you take sedatives, antipsychotics, antidepressants, diuretics, or medicines that affect heart rhythm.

Unwanted effects

Common or clinically recognised adverse effects include:

  • Dry mouth, nausea, constipation, or reduced appetite
  • Dizziness or light-headedness when standing
  • Insomnia, vivid dreams, or unusual alertness
  • Ankle swelling or mottled purplish skin discoloration
  • Blurred vision
  • Confusion, agitation, or hallucinations
  • Unsteadiness and falls

Older adults can be more sensitive to central nervous system effects. A person may appear unusually sleepy one day and confused the next. New hallucinations, marked agitation, or a sudden change in walking should be reported promptly because they may indicate excessive exposure or another medical problem.

Serious reactions are uncommon but include severe confusion, psychosis, seizures, fainting, serious allergic reactions, and dangerous heart rhythm disturbance in susceptible people. Amantadine can also worsen livedo reticularis, a net-like purplish skin pattern, and peripheral oedema.

Patients sometimes blame every new symptom on Parkinson’s disease. A practical clue is timing: symptoms that begin after a dose increase, appear repeatedly after each intake, or improve after a supervised dose change deserve a medication review.

One easily missed problem is insomnia. Taking an afternoon or evening dose may make sleep more difficult, while taking the medicine too early can leave motor symptoms less controlled later in the day. Timing changes should be agreed with the prescriber rather than handled by repeatedly adding or removing doses.

Rise slowly from a chair or bed during the first days of treatment or after a dose change. Amantadine-related dizziness can combine with Parkinson’s disease postural instability and increase fall risk.

Mechanism of action

Amantadine acts within the central nervous system through more than one pathway. It has dopaminergic effects and also reduces activity at N-methyl-D-aspartate (NMDA) receptors. NMDA receptors respond to glutamate, a major excitatory neurotransmitter involved in nerve signalling.

The dopaminergic action may increase dopamine release and reduce dopamine reuptake in certain brain regions. NMDA receptor antagonism may reduce excessive excitatory signalling linked with dyskinesia. These combined actions help explain why Amantadine can have a different clinical role from levodopa, which primarily replaces dopamine through its metabolic conversion in the brain.

Common mistakes

Several practical errors can reduce benefit or increase harm:

  • Taking an extra pill when dyskinesia appears unexpectedly.
  • Taking a forgotten dose together with the next scheduled dose.
  • Taking a late dose and then assuming the medicine has caused permanent insomnia.
  • Stopping suddenly because symptoms have improved.
  • Failing to mention kidney disease or dialysis.
  • Mixing the treatment with sedating medicines without a medication review.
  • Assuming hallucinations are an unavoidable part of Parkinson’s disease.
  • Changing levodopa timing at the same time as changing Amantadine, making the response difficult to interpret.
  • Driving before understanding whether dizziness, blurred vision, sleepiness, or confusion occurs.

Keep one medication schedule. Recording each change prevents accidental double dosing and helps the prescriber interpret the response.

Comparison

Amantadine and levodopa work through different pharmacological pathways. Levodopa is converted to dopamine in the brain, while Amantadine modifies dopaminergic transmission and reduces NMDA-mediated excitatory signalling.

Treatment approach Main pharmacological role
Amantadine alone May provide symptomatic support in selected parkinsonian disorders
Levodopa alone Replaces dopamine more directly and often provides stronger relief of bradykinesia and rigidity
Combined treatment May address motor symptoms while Amantadine targets dyskinesia or additional fluctuations

In advanced Parkinson’s disease, Amantadine may be added when involuntary movements develop during otherwise useful levodopa treatment. The aim is not always to produce a dramatic increase in walking speed. A more realistic goal may be fewer troublesome dyskinetic periods or smoother movement across the day.

Combining medicines can also increase complexity. Dizziness, hallucinations, sleep disruption, ankle swelling, and confusion may be caused by Amantadine, levodopa, the combination, or the underlying disease. The timing of each symptom helps the prescriber identify the likely contributor.

Evidence reviews have found that Amantadine can reduce dyskinesia in some people with Parkinson’s disease, though the strength and duration of benefit vary. Clinical protocols from academic neurology services, including Seoul National University Hospital, generally treat medication adjustment as an individual process rather than a fixed sequence [2].

What doctors say

Neurologists usually assess Amantadine by looking at function rather than a single symptom score. They may ask whether dressing, walking, turning in bed, eating, speaking, or using the hands has become easier. Dyskinesia diaries can reveal patterns that are missed during a short appointment.

A common clinical observation is that benefit can be modest but meaningful. A person may not describe feeling dramatically different, yet may spend less time with involuntary movements or complete daily tasks with fewer interruptions.

Prescribers also watch for a narrow margin between motor benefit and central adverse effects. Hallucinations, confusion, vivid dreams, ankle swelling, and insomnia may appear before the patient recognises that the medicine is contributing. The FDA prescribing information and neurological reviews emphasise dose adjustment when renal clearance is reduced [3].

What customers often ask

What happens when Amantadine is stopped, and does it need tapering?

Stopping regular Amantadine suddenly can bring back tremor, stiffness, gait disturbance, pain, weakness, dyskinesia, or wearing-off symptoms. Confusion or delirium can also occur in susceptible people. FDA prescribing information available in 2017 describes the need for caution when discontinuing antiparkinsonian treatment, while the TGA continues to recognise renal and neurological factors in safe use. A prescriber should set the tapering schedule according to treatment duration, kidney function, and motor response.

What should happen if the expected result does not come?

A lack of improvement does not mean that taking extra pills is appropriate. The clinician may review the diagnosis, timing of symptoms, kidney function, levodopa schedule, sleep, falls, and adverse effects before deciding whether to adjust or stop treatment. EMA Parkinson’s disease information dated 2024 supports assessing medicines against practical motor function rather than relying only on a single symptom. A symptom diary showing dose times and movement changes can make that assessment more precise.

Can Amantadine be combined with other medicines or supplements?

Amantadine may be combined with levodopa or other Parkinson’s treatments when a neurologist considers the combination appropriate. Extra caution is needed with sedatives, antipsychotics, medicines affecting heart rhythm, and products that may worsen dizziness or confusion. WHO medicines-safety principles published in 2023 support a complete medication review, including non-prescription supplements, because interaction risk depends on the whole regimen. Avoid adding a new supplement for sleep, alertness, or movement symptoms without checking its ingredients and effects.

Can Amantadine affect driving, concentration, or machinery work?

Amantadine can cause dizziness, blurred vision, sleep disturbance, confusion, hallucinations, or reduced coordination in some people. These effects may impair driving, climbing, cycling, or operating machinery, particularly after starting treatment or changing the dose. The Australian TGA and EMA, in guidance available in 2024, advise attention to activities requiring alertness when central nervous system effects are possible. Do not drive or use machinery until you know how the prescribed regimen affects concentration and balance.

Do you offer anonymous delivery?

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.

Comparison

Amantadine Current

Active ingredient: Amantadine
100mg 50mg
From $ 33.82
pills
3.6 (5)

Aricept

Active ingredient: Donepezil
10mg 5mg
From $ 210.04
pills
3.8 (4)

Azilect

Active ingredient: Rasagiline
1mg
From $ 80.10
pills
3.8 (4)

Modvigil

Active ingredient: Modafinil
100mg 200mg
From $ 160.20
pills
4.3 (3)

Neurontin

Active ingredient: Gabapentin
100mg 300mg 400mg 600mg 800mg
From $ 72.98
pills
3.8 (3)

Sibelium

Active ingredient: Flunarizine
10mg 5mg
From $ 396.94
tablets
3.8 (4)

How the medicines for Neurology compare

Sources

  1. U.S. Food and Drug Administration (2017). Symmetrel (amantadine hydrochloride) prescribing information.
  2. Cochrane Database of Systematic Reviews (2003). Amantadine for dyskinesia in Parkinson’s disease.
  3. European Medicines Agency (2019). Summary of Product Characteristics (SmPC) — amantadine-containing medicinal product

How Buyers Rate Amantadine

Based on 5 reviews

Neil, 52 Verified
Rating: 4 out of 5

I used Amantadine alongside my Parkinson’s treatment for about six weeks. The twisting movements after breakfast became less intrusive, although my mouth felt dry and I had to be more careful with fluids.

About six weeks 10 Oct 2026
Craig R., 57 Verified
Rating: 4 out of 5

The first fortnight was mixed. Walking felt a little smoother, but I became restless at night and started waking around 3 am. Moving the timing earlier helped, but the improvement was not large enough to ignore the sleep problem.

The first fortnight 17 Oct 2026
Peter T., 46 Verified
Rating: 4 out of 5

I noticed fewer involuntary arm movements after several weeks. I still had stiffness before the next levodopa dose, so Amantadine did not solve every fluctuation.

Several weeks 24 Oct 2026
Jonathan, 62 Verified
Rating: 2 out of 5

I stopped taking it suddenly after feeling better and became very stiff, weak, and unsteady within a few days. My neurologist restarted treatment and reduced it gradually later.

31 Oct 2026
Michael, 48 Verified
Rating: 4 out of 5

The tablets were easy to take, and I felt more settled during the afternoon. I also developed ankle swelling, which improved after the treatment plan was changed.

7 Nov 2026
Get our free app Shop faster and track your orders 3.8 · 491 reviews Install